AXLRx Book a callCommission

Analysis types

What each analysis answers, and which run as modules.

01 · Market Intelligence · 43 reports · CI Team · Launch Lead Competitive Intelligence Who controls which cohort, and on what evidence. Drug-by-drug commercial posture, prescribing share and payer positioning. Browse CI → 01 · Market Intelligence · 43 reports · CI Team · Medical Affairs Disease Landscape Disease burden, diagnosis rates and the treatment pathway. The market map you build commercial strategy on. Browse DL → 02 · Sizing & Access · 34 reports · Forecasting · Launch Lead Patient Flow Model An incidence-to-eligible funnel built as a live, re-runnable Excel model: 8 sheets, 119 formulas, zero hardcoded cells. Every conversion step sourced, every assumption editable. Browse PFM → 02 · Sizing & Access · 43 reports · Market Access · HTA Lead Payer & HTA Coverage criteria and the evidence standard. How payers and HTA bodies evaluate access and step-edits. Browse P&HTA → 03 · Commercial Planning · 1 report · Sales Ops · Commercial Planning Field-Force Strategy How the prescriber base, reimbursement channel and targeting gate should shape field deployment. Account depth vs. reach, channel coverage, and territory design. Browse SFE → 03 · Commercial Planning · 43 reports · Launch Lead · BD Launch Readiness The competitive, epidemiological, and payer-readiness case for entering a market before launch. What a pre-launch asset needs to prove, size, and prepare for. Browse LR → 01 · Market Intelligence · 23 reports · Medical Affairs · Commercial Lead KOL Mapping A six-sheet KOL universe and engagement workbook, built gate by gate: sizing, tier classification, scientific influence, engagement readiness, MSL territory coverage, and cross-border network. Every KOL entry carries a verification tag. Browse KOL → 02 · Sizing & Access · 38 reports · Market Access · Pricing Lead Pricing Strategy Model A 12-sheet pricing architecture built market by market: price ladder, international reference-price basket, value-based ICER, gross-to-net waterfall, launch sequencing, and revenue scenarios — not a single number, a re-runnable model. Browse PSM → 02 · Sizing & Access · 37 reports · Forecasting · Strategy Lead Market Sizing Model A static, triangulated patient-count model, not a forecast: 5-sheet workbook (Cover, Model, Research Validation, QC, Sensitivity), every input sourced and re-runnable. Sizing answers how many patients exist today; forecasting is a separate question. Browse MSM → 02 · Sizing & Access · 11 reports · Market Access · HEOR Lead HTA Strategy Model A 9-sheet HTA submission-strategy model: authority landscape, PICO framework, comparator defence, value-dossier self-assessment, HEOR gap register, and submission timeline — built before the dossier is written, not after. Browse HTA →